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Other names: env; enverin; Env-W; HERV-W; 
HERV-W-ENV; HERV-W_7q21.2 provirus ancestral 
Env polyprotein precursor; HERV-7q; HERVW; 
Syncytin; Syncytin-1 
Location: 7q21.2 
Note: Sequences of retroviral origin represent about 
8% of the human genome. There are at least 31 families 
of human endogenous retroviruses (HERVs). Each 
family derived from an independent infection of the 
germ line by an exogenous virus during the evolution 
of the human lineage. The infectious retrovirus 
founding the contemporary HERV-W family entered 
the human ancestor genome after the divergence 
between Catarrhini and Platyrrhini, i.e., less than 40 
million years ago. The spread of the HERV-W family 
into the genome essentially results from events of 
intracellular retrotransposition of transcriptionally 
active copies, a phenomenon mediated either by their
own reverse transcriptase (RT) machinery or by RT 
from LINE elements. Generally, due to the absence of a 
selective pressure, HERV-W elements have 
accumulated inactivating substitutions (frame-shift, 
nonsense mutations), leading to complex multicopy 
families whose transmission is exclusively Mendelian. 
Thus, the contemporary HERV-W family consists of 
collections of heterogeneous elements, ranging from 
full-length defective proviruses (gag, pol, and env 
genes flanked at both extremities by two long terminal 
repeats (LTRs)) to isolated LTRs derived from 
recombination events. The human endogenous 
retrovirus HERV-W multicopy family includes a 
unique proviral locus, termed ERVWE1, which 
contains gag and pol pseudogenes and has retained a 
full-length envelope open reading frame (ORF) also 
named Syncytin or Syncytin-1. ERVWE1 is a bona fide





Figure 1: ERVWE1 provirus genomic structure and 7q21.2 chromosomal environment: Flanking black boxes correspond to the 24th 
exon and the 5th exon of the PEX1 and ODAG genes, respectively, defining a LTR element-rich region of 30 kb in human 7q21.2. 
Isolated LTR elements are depicted as red boxes (MaLR LTR) and green boxes (HERV-P LTR). U3 (white), R (hatched) and U5 (dark 
grey) regions of 5' and 3' LTRs of ERVWE1 provirus are indicated. U3, R and U5 regions of 5' and 3' LTRs of HERV-H provirus LTRs 
are labelled in purple. Short direct repeats (light grey and dark grey arrows) located at each boundary of ERVWE1 and HERV-H 
proviruses indicates that integration of each element was mediated by an HERV-family specific reverse transcriptase. Pseudogenes 
(labelled ∆) are shown as boxes. The Syncytin-1 open reading frame is depicted by a large orange arrow. A 2-kb intron (black line) is 
located just downstream of the 5' ERVWE1 LTR. A double arrow indicates the ERVWE1 transcriptional regulatory region (see figure 3). 
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Figure 2: ERVWE1 evolution and selection in primates. 
 
Figure 3: ERVWE1/Syncytin-1 transcriptional regulatory element: ERVWE1/Syncytin-1 expression is regulated by a bipartite element 
consisting of a cyclic AMP-inducible LTR retroviral promoter (ERVWE1 5'LTR U3 region) adjacent to an upstream regulatory element 
(URE) of composite origin. This URE consists of a 208 bp non-retroviral, non-repeated/transposable cellular sequence (non-TE region) 
and a 228pb MaLR LTR containing a trophoblast specific enhancer (TSE) which confers a high level of expression and placental 
tropism. True (top black boxes) and putative (bottom grey boxes) transcription factor binding sites along ERVWE1 5'LTR and URE are 
indicated. The positive (+) or negative (+) involvement of regulatory domains in placental tissue is annotated below the schematic 
representation. The CAP transcription initiation site (arrow) is located at the 5' end of the R region. 
 
Figure 4: ERVWE1 splicing strategy in placenta: The CAP transcription initiation site (right arrow) is located at the 5' end of the R region 
of the 5'LTR. The polyadenylation signal (left arrow) is located toward the 3' end of the R region belonging to the 3'LTR. ERVWE1 
produces three major single-spliced transcripts in placental tissue, the subgenomic 7.4-kb and 3.1-kb mRNAs and the fully-spliced 1.3-
kb mRNA. Only the 3.1-kb variant is responsible for Syncytin-1 translation. Splice donor (SD) and acceptor (SA) sites are indicated by 
right and left arrows, respectively. SD and SA were identified by screening a placental cDNA library. SD2 site was identified in a single 
clone. 
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DNA/RNA 
Description 
DNA STRUCTURE  
ERVWE1 is a 10.2-kb long full-length provirus 
integrated on chromosome 7q21.2. Like the proviral 
form of simple exogenous retroviruses, ERVWE1 is 
structurally composed of two long terminal repeats 
(LTRs), flanking the internal sequence containing ga , 
pol and env genes. Each LTR is composed of three 
regions, i.e. from 5' to 3'U3, R and U5. As in other 
proviruses, the U3 region of ERVWE1 5'LTR serves as 
proviral promoter and the R region of the 3'LTR acts as 
a polyadenylation signal. Both gag and pol genes, 
normally coding respectively for the matrix, capsid and 
nucleocapsid proteins, and for the viral enzymatic 
machinery, are disrupted by stop codons. Only the full-
length env gene that codes for the envelope 
glycoprotein, Syncytin-1, is functionally preserved. In 
addition ERVWE1 contains a 2-kb intron, at the 
5'LTR/gag junction, with no trivial homology or known 
function. 
CLASSIFICATION  
The current classification and nomenclature of ERVs is 
complex and varies between and within species. 
Retroviral classification is initially based on virion 
morphology during maturation and assembly of 
particles at the cell membrane. Accordingly, 
retroviruses are designated A-, B-, C- and D-type. 
ERVs are also classified on the basis of the similarity 
of their pol region to those of exogenous retroviruses. 
This point is illustrated in class I and II which group 
the pol MuLV-like (Murine Leukemia Virus) and the 
pol MMTV-like (Mouse Mammary Tumor Virus) 
ERVs, respectively. The International Committee on 
Taxonomy of Viruses (I.C.T.V., 
http://www.ncbi.nlm.nih.gov/ICTVdb/index.htmlhttp://
www.ncbi.nlm.nih.gov/ICTVdb) has established seven 
genera of Retroviridae, Alpha-, Beta-, Gamma-, Delta-, 
Epsilon-retrovirus, Lentivirus and Spumavirus. The 
ERV nomenclature is heterogeneous and complex due 
to the difficulty to associate HERVs with 
physiopathological functions. It is mainly based on the 
Primer Binding Site (PBS) sequence, which is 
recognized by a specific tRNA whose one letter code 
then becomes the ERV suffix. As the PBS located 4 bp 
downstream from the U5 subdomain of the 5' 
ERVWE1 LTR showed extensive homology with the 
avian retroviruses PBS used by tRNATrp (single letter 
code: W) for minus-strand DNA synthesis, this family 
was tentatively named HERV-W. Phylogenetic trees 
within the pol region showed that the HERV-W family 
is related to ERV-9 and RTVL-H families and thus 
belongs to the class I endogenous retroviruses. The 
homologies within the pol and env genes with the 
murine type C and simian type D retroviruses, 
respectively, suggest a chimeric genome structure as 
described for baboon endogenous virus. Based on the 
size criteria, such a chimerism seemed to exist within 
the LTR: the 247-nt U3 and the 79- to 81-nt R elements 
were comparable to avian or type D retrovirus U3 and
mammalian type C R elements, respectively, although 
the 410- to 455-nt U5 element remained unclassified as 
unusually long. According to the new classification, 
HERV-W elements belong to the genus of 
gammaretroviruses. No replication-competent elements 
could be found within the HERV-W family and no 
corresponding exogenous retrovirus have been 
characterized. 
EVOLUTION  
HERV-W family: ERV-W elements are detectable in 
the genome of all Catarrhini, i.e. Hominidae (the 
human, chimpanzees, gorillas, orangutans), 
Hylobatidae (gibbons) and Cercopithecidae (Old World 
monkeys), but not in Platyrrhini (New World monkeys) 
nor in other more distant primates. Thus, the HERV-W 
family entered and began to spread in the genome of 
primates after the divergence of the Catarrhini and 
Platyrrhini, i.e. less than 40 million years ago (MYA). 
It has been estimated, based on the divergence of 
sequences, that the main period of spreading of the 
HERV-W family within the genome lasted for about 5 
M years, between 15.5 to 28.6 MYA, before the 
Catarrhini divergence in Hominoidae and 
Cercopithecidae. The HERV-W family thus remained 
transcriptionally active over a short period of primate 
evolution, in contrast to other HERV families. This 
spreading gave rise in the human haploid genome to at
least 1401 integration events, that can be classified nto 
3 subfamily, the subfamily 1 being the oldest. Many of 
them have recombined into solitary LTRs (343 to 1100 
solo LTRs), and a large portion have been generated by 
Line1 retrotranspositional machinery (176 
pseudogenes). Today only 29 to 39 proviruses are still 
full length and none has remained competent for 
replication due to frameshifts and stop codons within 
the ORFs for gag, pol and/or env. Only 30 env HERV-
W related regions can be found in the genome, as 
compared to 70 gag and 100 pro regions, indicating a 
preferential loss of the envelope. In addition, only 5 
ORFs longer than 1000 bp have been preserved: one 
gag, one pro, one pol, one full-length env (Syncytin-1) 
and one truncated env. Among these ORFs, only two 
proteins seem to be produced: a Gag protein encoded 
on a HERV-W pseudogene, and Syncytin-1, encoded 
by ERWE1, the unique full-length envelope 
glycoprotein. 
ERVWE1 integration: ERVWE1 integration occurred 
in the germ line of a Catarrhini ancestor before 
Hominoidae and Cercopithecidae divergence more than 
19-25 MYA, as indicated by the identification of a 
deleted ERVWE1 orthologous locus in Old World 
Monkeys. ERVWE1 integrated on chromosome 
7q21.2, into an old MaLR-e1 solo LTR. The presence  
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in several species of 4-6 bp direct repeats, althoug  
degenerated, at both ends of the provirus attestes that 
ERVWE1 was generated by a retrovirus-like 
integration event, i.e. by using a functional ERV-W 
reverse transcriptase. However, whether it resulted 
from a re-infection, cis- or trans-retrotranspostion event 
remains unknown. The presence of a 12 bp deletion in 
the env gene of ERVWE1 provirus in Hominoids and 
Cercopithecs suggests that this deletion, crucial for the 
Env fusogenic activity (see below, Protein), occured 
originally in a primary Catarrhini ancestor possibly 
soon after integration, in the youth of the ERV-W 
family. As ERVWE1 is part of the subfamily 3 of 
HERV-W elements, which is probably the youngest, 
this support the hypothesis that the HERV-W family 
remained active during a short period during primates 
evolution. This 12-bp deletion constitutes a signature, 
specific to ERVWE1. As it was shown to be unique 
among all ERV-W copies in human and chimpanzee 
genomes, this suggests that ERVWE1 did not 
retrotransposed after its integration and furthermore 
was not expressed in the hominoid germ line, as 
opposed to many other HERV-W loci which 
retrotransposed as cDNA structures (pseudogenes) 
using Line-1 reverse transcriptase machinery. 
ERVWE1 conservation and selection in Hominoidae:  
- Conservation: After integration within the Catarrhini 
genome, ERVWE1 genomic structure followed two 
divergent evolutionary pathways, a genetic drift in 
Cercopithecus sp. versus a domestication, in 
Hominoidae sp. (Hominidae and Hylobatidae). More 
precisely in Cercopithecus sp. an about 9 kb region was 
deleted comprising the 4.3 kb LTR-gag-pol 5' fraction 
of the ERVWE1 provirus, and the env ORF became 
further inactivated by accumulation of stop codons a d
frameshift mutations. In Hominoidae (Hominidae and 
Hylobatidae), on the contrary, ERVWE1 structure has
been preserved, as well as the surrounding genomic 
structure within a 30 kb area. gag and pol regions 
contain numerous stop codons and frameshifts in all 
Hominoidae, while Syncytin-1 ORF has been 
conserved. 
- Selection: Diverse facts emphasize the selective 
pressure on ERVWE1 locus in the Hominoidae lineage 
and the recruitement of its envelope gene to become a 
bona fide gene involved in placental morphogenesis. 
Notably comparative analysis of the ERVWE1 locus 
for 24 individuals showed a variable pattern of 
sequence variation along the proviral locus, that is 
compatible with a positive pressure on the elements 
critical for env activity maintenance. 
- Enhancer: The MALR-e1 LTR portion located 
upstream of the ERVWE1 provirus has been shown to 
act as a trophoblast specific enhancer (TSE) that co-
opted with the ERVWE1 5'LTR promoter, conferring 
on Syncytin-1 a specific and high activity in the 
placenta. This sequence is particularly conserved in  
humans as no polymorphism was observed in 48 
sequences analyzed and is also strictly identical in all 
Hominidae sp. analyzed. In contrast, the portion located 
downstream of the provirus is different for each 
Hominidae species. The MaLR co-optation however 
seems to be Hominidae-specific, as in the gibbon 
(Hylobatidae), the MaLR is deficient in enhancer 
activity. In contrast the gibbon 5'LTR presents higher 
promoter activity. 
- Promoter: The 5'LTR exhibits an unusually low 
polymorphism (one variable site in 18.0 kb) as 
compared to the variability described for noncoding 
sequences (one every 0.47 kb) and repeated sequences 
(one every 0.31 kb), suggesting that there has beena 
selective sweep of this region. Conversely, the 
variability of the 3'LTR (one in 0.5 kb) is typical of 
repeated sequences. On line with this, the functional 
analysis of all U3 elements revealed that the human and 
other apes ERVWE1 5' LTRs were always more active 
in BeWo cells than the ERVWE1 3' LTRs. 
- Transcriptional termination and postranscriptional 
signals: In all Hominoidae including the gibbon, the 
poly-A signal within the 3'LTR and the post-
transcriptional regulation elements (env ATG context, 
5' and 3' UTRs and splice sites including those for the 
env mRNA processing) are strictly identical. 
- Envelope: ERVWE1 env, Syncytin-1, was shown to 
be the most conserved env ORF of the 16 human 
proviruses (from 9 HERV families) still containing a 
env gene, even though it is the fourth oldest. The 
observed variability of the env ORF (one variable sit
every 2.2 kb) fell within the same range as the 
variability described for human coding sequences (one 
every 1.08-2.00 kb), highlighting that the behavior of 
this gene of retroviral origin is similar to any ess ntial 
cellular gene, as opposed to infectious retroviruses or 
more generally RNA-based organism. The critical 
domains essential for classical retroviral envelope 
expression and function are highly conserved and 
clearly under functional constraint in the entire 
Hominoidae lineage. Most of the amino-acid changes 
in Syncytin-1 evolution are located in positions that are 
variable across env proteins (surface domain involved 
in receptor recognition and binding, intracytoplasmic 
tail involved in fusogenic activity regulation), whic  
could represent gradual adjustment to its cellular 
function. Interestingly, based on sequences comparison 
and according to the most parsimonious scenario, one 
of the nonsense mutations found in Cercopithecus 
lineage, which eliminates the last 30 amino-acids of the 
env protein, occured in the Catarrhini ancestor but
reverted in Hominoidae re-establishing the full-length 
env ORF. Furthermore, the ERVWE1 signature, which 
consists of four amino-acid (12-bp) deletions in the 
intracytoplasmic tail of the glycoprotein, were shown to 
be crucial for the envelope fusogenicity and all tested 
Hominoidae Syncytin-1 proteins present similar  
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fusogenic activity in heterologous cell fusion assay . 
Convergent evolution of endogenous retroviral 
envelopes: Another fusogenic endogenous retroviral 
envelope, Syncytin-2, has been functionally preserved 
in the human genome. Like Syncytin-1, Syncytin-2 is 
highly expressed in the placenta and thought to be 
involved in placental morphogenesis. Although not 
fusogene, a third endogenous reroviral envelope is 
believed to be involved in placenta development: it is 
the envelope gene of ERV3 provirus, whose function is 
associated with cell differentiation/proliferation. 
ERVWE1/Syncytin-1 and ERVFRDE1/Syncytin-2 are 
specific to primates and thus do not exist in other 
placentae. However, this apparent endogenous 
retrovirus hijacking for placentation use is not 
restricted to the primates. Indeed two unique 
endogenous envelope genes of retroviral origin have 
been found in the mouse, i.e Syncytin-A and -B. They 
both display fusogenic activity and specific expression 
in the syncytiotrophoblast-containing labyrinth. They 
are found in all Muridae tested and show striking 
conservation of their env coding status. In addition, the 
envelope of a particular class of sheep ERV, 
endogenous Jaagsiekte sheep retroviruses (enJSRVs), 
regulates trophectoderm growth and differentiation in 
the periimplantation conceptus and when blocked leas 
to pregnancy loss. Altogether the data strongly argue 
for convergent evolution of endogenous retroviral 
envelopes to serve for placentation in mammals. 
REGULATION  
Note: ERVWE1 transcriptional activity was shown to 
be regulated by several transcription factors 
(cAMP/PKA pathway, Oct-1, GCMa, AP-2, Sp-1), 
hormones (steroid hormones: oestrogen and 
progesterone), cytokines (TNF-alpha, INF-gamma, 
IFN-beta, IL-6, IL-1), environmental conditions 
(hypoxia), exogenous virus infections and epigenetic 
methylation processes. 
Promoter region description: The ERVWE1 promoter 
is a bipartite element consisting of a retroviral promoter 
(the 5'LTR) and a 'cellular' regulatory region, called the 
URE, within the 436 pb sequence of the directly 
upstream ERVWE1 integration site. 
- URE: The 436 bp URE is composed of three sub-
domains: a cellular positive regulatory region from -
436 to -128, a negative regulatory region from -128 to -
67, and a trophoblast specific enhancer (TSE) from -67 
to -35, all contained in the MaLR-e1 LTR. In the distal 
positive URE (-436 to -128), computational analyses 
indicated putative binding sites for transcription factors 
previously found to be involved in placental promoter 
regulation (Ap-2, Sp-1, PPAR-gamma, GATA, c-Myb, 
and GCMA), as well as for NF-kappaB (-214/-204) and
Ap-1 (-146/-136). The p65/p50 NF-kappaB 
heterodimer binds to the distal URE NF-kappaB site. 
This binding site and the Ap-1 binding site are crucial 
for the positive regulation of Syncytin-1 expression by 
TNF-alpha, IFN-gamma, IL-beta, IL-6 and PMA as 
well as for its negative regulation by IFN-beta in 
astrocytes. However, activation by the two interleukins 
(IL) does not require binding of the p65/p50 
heterodimer to the NF-kappaB site. The central URE 
negative regulatory region contains another Ap-1 
binding site as well as binding sites for glucocorti id 
and progesterone receptors. However, these sites 
remain putative. The distal positive URE (-436 to -128) 
and the central negative URE (-128 to -67) have 
compensatory effects in the BeWo placenta cell line. 
Putative binding sites for ubiquitous Ap-2, Sp-1 and 
placenta-specific GCMa are essential constituents of 
the TSE. Sp-1 and GCMa effectively bind to these Sp-1 
and GCMa binding sites respectively. The binding of 
GCMa greatly enhances promoter activity specifically 
in placenta cells. The most proximal region to the 
5'LTR (-35 to +1) contains putative binding sites for c-
Myc and two sites for placenta specific GATA 
transcription factors. GATA 2 and 3, but not GATA 1 
and 4, are able to bind in this region, and the intgri y 
of both GATA sites seems to be needed for GATA 2 
and GATA 3 binding and placenta-specific positive 
regulation of ERVWE1 transcription. 
- 5'LTR: The retroviral promoter is formed by the U3 
region, like other simple retroviruses. A little inh bitor 
activity has been found in the U5 region. The U3 
region is 247 bp long and can be sub-divided into tw
regions: a region responsible for basal placental activity 
from +1 to +125, and a core promoter from +125 to 
+310. Indeed, progressive deletions into the first 125 
bp of the 5' region induce a corresponding progressiv  
decrease in the promoter activity of the LTR, in 
different cell types, but activity always remains higher 
in placenta cells. This region contains several putative 
binding sites for ubiquitous and placenta specific 
transcription factors (GATA, Pit-1a, two Sp-1, Ap-2, 
Oct-1, PPAR-RXR and another GATA). The Sp-1 and 
Ap-2 binding sites spanning the region +55 to +74 have 
been found to be essential for LTR activity, but remain 
putative. Interestingly both of them are localised in an 
oestrogen response element (nt +51 to +87). DNA 
binding assays showed that purified ERalpha bound 
specifically to this ERE. Oestrogen (E2, 2-OH-E2, 4-
OH-E2) as well as progesterone induces Syncytin-1 
transcription up to 20 fold (after three days of growth 
and treatment) and also induces the other ERVWE1 
mRNA species. The distal part of the U3 region (+125 
to +247) is defined as the minimal promoter region. 
Indeed, this core promoter is active in all cell types. It 
contains an Oct-1 binding site and conventional CAAT 
and TATA boxes located at 43 and 26 bp upstream of 
the R CAP site (+248), and separated from each other 
by one Ap-2 and two Sp-1 putative binding sites. Oct-
1, but not Oct-2, Oct-4 or Oct-6, binds to the Oct-1 
binding site, which is also essential to core promoter 
activation. The functional roles of CAAT and TATA 
boxes have been confirmed by mutant analyses, and 
this region was found to be induced by the 
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cAMP/Protein Kinase A pathways. Furthermore 
cAMP/PKA stimulates GCMa association with CBP, 
and GCMa acetylation by CBP. This leads to the 
stimulation of ERVWE1 promoter activity. Note that 
GCMa also binds on a very distal binding site (about 
2535) and is also involved in the high placenta 
transcriptional activity of ERVWE1. 
Exogene stimuli:  
- Environment: Hypoxia reduces the Syncytin-1 
transcription level as demonstrated in cytotrophoblast 
BeWo cells, primary trophoblasts cultures, ex vivo 
perfused placental cotyledons under hypoxic conditions 
and observed in placental diseases associated with 
hypoxia, and overexpression of SOD-1 (superoxide 
dismutase-1), a regulator of oxygen species, also 
reduced Syncytin-1 transcription. Gene repressive 
effects of oxygen deficiency can be compensated by 
induction of the cAMP/PKA pathway. in vitro serum 
deprivation gives rise to an increase in the transcription 
of HERV-W elements, including ERVWE1. 
- Virus transactivation: Herpes virus simplex type I 
(HSV-1) and Influenza virus A/WSN/33 infections can 
transactivate ERVWE1 5'LTR as observed in vitro in 
neuronal and brain endothelial cells and in tumoral cell 
types. HSV immediate early proteins IE1 and IE3 both 
trigger ERVWE1 5'LTR activity, and when co-
expressed act synergically to stimulate the ERVWE1 
5'LTR promoter. HSV-1 IEs seem to mediate enhanced 
binding of Oct-1 to its cognate binding site (nt 144-
168). The mechanisms by which Influenza A/WSN/33 
activates the ERVWE1 promoter are unknown. 
However ERVWE1 transactivation by both viruses 
correlated with a corresponding elevation in IFN-beta 
transcription in SK-N-MC neuroepithelioma cells. 
Conversely, the observation that IFN-beta decreases 
ERVWE1 URE-LTR promoter activity in U-87MG 
astrocytic glial cells suggests complex regulatory 
mechanisms. 
Epigenetic: Imprint hypothesis: it has been suggested 
that the Syncytin-1 locus, ERVWE1, could be 
regulated by an imprinting mechanism, and more 
particularly by a maternal imprint. The hypothesis is 
based on the biological function of Syncytin-1 in 
placental, and thus embryonic, development, and on the 
proximity of the locus to two other maternally 
imprinted genes that are temporally regulated in the 
same manner as Syncytin-1 during pregnancy, one of 
these two imprinting genes being another retroelement 
(PEG10). However, this hypothesis has not yet been 
confirmed. The influence of methylation on the 
ERVWE1 U3 retroviral promoter has been investigated 
and was shown to suppress its activity in HeLa and 
BeWo cells. Correlating with methylation control of
ERVWE1 transcriptional capacity, the U3 region was 
found to be highly methylated in several cell types and 
lines (skin fibroblasts, PBMC, one breast carcinoma 
sample, HeLa) where Syncytin-1 is not expressed, or 
not systematically expressed in the case of breast 
cancers. It was found likewise to be highly 
hypomethylated in full-term placenta samples and 
completely unmethylated in placental BeWo cells. Note 
that a global hypomethylation of HERV-W LTRs 
elements was found in ovarian malignant tissues. 
Transcription 
RNA: SPLICING STRATEGY  
ERVWE1 full-length transcript, which would include 
the 2-kb intron, has never been detected. Though, 
ERVWE1 provirus produces 3 major monospliced 
transcripts. The first one is 7.4 kb long. It corresponds 
to a splice of the 2 kb intronic sequence (SD1/SA1), 
and thus contains the gag, pro/pol and env frames. The 
second one is 3.1 kb long and results from the splice of 
the 2-kb intron, gag and pro/pol sequence (SD1/SA2). 
It thus contains only the env gene and is responsible for 
Syncytin-1 translation. The third produced transcript is 
a 1.3 kb long fully spliced transcript (SD1/SA3). Other 
splice variants may theoretically exist, as at least 
another splice donor located at the env 5'UTR/ORF 
junction (SD2) was found to be used in association 
with the SA3 splice acceptor near the end of the ORF, 
eliminating the full env region in one placenta cDNA. 
Physiological transcription of the ERVWE1 locus has 
been detected in several tissues. Transcription levels 
however are mainly low as demonstrated by the need 
for sensitive detection techniques such as RT-PCR or 
EST analyses. Besides, placental and, to a lesser extent, 
testicular tissues have high ERVWE1 transcriptional 
activity as indicated by Northern blotting detection. In 
addition, ERVWE1/Syncytin-1 mRNAs have been 
detected in multiple sclerosis and tumoral tissues as 
well as cancerous cell lines. Table 1 shows all tissue  
where ERVWE1 and/or HERV-W env type transcripts 
have been reported. The finding of ERVWE1-specific 
transcripts are indicated, however the list may be not 
exhaustive. Moreover, these results must be treated 
with caution as (i) the biological significance of l w 
expression levels could be questioned, and (ii) the 
Syncytin-1 sequence is present within both the 7.4 kb 
transcript (e.g. in the testis and placenta), and the 
Syncytin-1 producing 3.1 kb mRNA (to date observed 
exclusively in the placenta). 
TRANSCRIPTION  
Placental Syncytin-1 3.1kb mRNA expression occurs 
specifically in trophoblast cells (extravillous 
cytotrophoblasts, villous cytotrophoblasts, and the 
syncytiotrophoblast layer), but not in placenta 
parenchymal cells such as fibroblasts. The variation in 
Syncytin-1 mRNA levels during pregnancy has been 
the focus of several studies but results are to some 
extent controversial. Thus during the first trimester 
ERVWE1/Syncytin-1 expression is relatively high but 
stable. Conflicting results were obtained concerning the 
latter trimesters: (i) the level of expression is reduced 
during the second trimester and increases again in the 
third trimester to reach its highest level; (ii) this level 
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increases progressively from the second to the third 
trimester and falls suddenly at term, (iii) at term, the 
expression level remains higher than in the first 
trimester or becomes lower. These discrepancies may 
be due to the amplification method (region amplified 
gag-pol versus env, ERVWE1 specificity, mRNA 
species specificity i.e. 7.4-, 3- kb or both) or the 
physiological sample. Indeed the observed loss of 
transcription during the second trimester is considere  
by the authors to be potentially an artefact linked to the 
medical -unknown- reason that lead to interruption of 
pregnancy in the second trimester. 
Protein 
Description 
ERVWE1 encodes a 538 amino-acid, 73-kDa 
glycosylated (53 kDa unglycosylated) envelope protein, 
Syncytin-1. Structurally, Syncytin-1 protein consist  of 
a 20 AA leader peptide at the amino end, a surface 
subunit (SU) (AA21-317) and a transmembrane subunit 
(TM) (AA318-538) at the carboxy end. Syncytin-1 is 
synthesized as a glycosylated gPr73 precursor that 
associates as a homotrimeric structure. Each precursor 
undergoes cleavage into two mature proteins: a gp50 
surface unit (SU), and a gp24 transmembrane unit 
(TM). The cleavage occurs at a furin cleavage site 
(RNKR) located at the SU/TM junction. SU and TM 
are further covalently linked through a disulphid bond 
between CWIC and CX6CC motifs of the SU and TM 
respectively and reach the cellular membrane. SU is 
responsible for recognizing and binding to specific 
receptors on the host cell. TM presents a hydrophobic 
fusion peptide (AA 320-340), and a fusion core made 
of N- and C-terminal heptad repeats (AA 352-392 and
AA 407-440 respectively). Heptad repeats are also 
involved in the homotrimerization of the above-
mentioned precursors. In addition TM contains an 
immunosuppressive region inside the C-terminal 
heptad repeat (AA377-396), a carboxy-transmembrane 
domain (AA444-469) for protein anchoring in the 
membrane and ends in a cytoplasmic tail. 
Function 
Receptor-binding: The intercellular fusion driven by
Syncytin-1 is activated on interaction of the SU subunit 
with a type D mammalian retrovirus receptor (RDR). 
Among RDR, HERV-W env efficiently uses two 
human sodium-dependant neutral amino-acid 
transporters as receptors, i.e. hASCT1/SATT/SCL1A4 
and hASCT2/ATB/SCL1A5. The minimal receptor 
binding domain, at least for interaction with hASCT2, 
consists of the N-terminal 124 AA of the mature SU. In 
particular a region of 18 residues containing a 
SDGGG(X)2D(X)2R motif, conserved among 
retroviruses of the same interference group, has been 
proved to be essential for Syncytin-1-hASCT2 
interaction. 
Fusion/differentiation: The intracytoplasmic tail of the 
TM subunit is essential for the fusion process. As 
mentioned above, TM presents a hydrophobic fusion 
peptide (AA320-340), and a fusion core made of C- 
and N-heptad repeats (AA352-392 and AA407-440 
respectively) able to form a highly thermo-stable coiled 
trimer. All these regions are needed for the fusion 
process of enveloped viruses. Yet it exhibits an unus al 
processing mechanism when compared with that found 
in infectious retroviruses. Indeed, retroviral envelop -
induced fusion is prevented by the inhibitory action of 
an R peptide located in the intracytoplasmic tail of the 
TM subunit. The R peptide is removed upon viral 
protease cleavage of the upstream cognate cleavage 
site, during or shortly after homotrimer retroviral 
envelopes reach the plasma cell membrane, allowing 
fusion to occur. ERVWE1 possesses a four amino-acid 
deletion (LQMV) after AA485 which eliminates the 
viral protease cleavage site. However far from 
disturbing fusion ability, this deletion has been shown 
to be crucial for Syncytin-1 fusogenicity. Thus no 
HERV-W retroviral protease any longer exists in the 
 
 
Figure 5: Organization of Syncytin-1 envelope glycoprotein: The surface (SU gp50, 22-317) and transmembrane (TM gp24, 318-538) 
domains are indicated in blue and yellow, respectively. They derive from the proteolytic cleavage of the gPr73 envelope precursor on the 
consensus furin cleavage site RNKR. The black dots indicate N-glycosylation sites (positions 169, 208, 214, 234, 242, 281, and 409). 
Gray boxes indicate the following conserved motifs: L, leader peptide (1-21); FP, fusion peptide (318-340); IM, putative 
immunosuppressive domain (377-396); TM (hatched), membrane anchorage domain (444-470). CYT, intracytoplasmic tail (471-538). 
The 124 N-terminal amino-acids of the HERV-W mature SU protein are sufficient to interact with the hASCT2 and hASCT1 amino-acid 
transporters and thus represent the receptor binding domain (RBD, medium blue). The 18AA-long SDGGGX2DX2R motif conserved 
among retroviruses of the same interference group (recognizing the same receptors) is indicated. Amine- and carboxy- heptad repeats 
(NHR 352-392, CHR 407-440) within the TM domain are indicated. They constitute the homotrimeric fusion active core structure which 
brings the phospholipid bilayers in two cells into close proximity, resulting in membrane fusion. The ERVWE1-specific LQMV deletion 
(del LQMV), absent from paralogous HERV-W copies, is indicated. This deletion within the CYT region is crucial for the Syncytin-1 
constitutive fusogenic activity. CWIC and CX6CC motifs involved in disulfide bonding of SU and TM domains are indicated. 
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human genome, as all protease ORFs are disrupted, and 
hence the integrity of the protease cleavage site would 
not have helped remove the inhibitory R peptide. 
Furthermore, LQMV deletion also leads to loss of 
inhibition control by the R peptide, making Syncytin-1 
constitutively fusion competent, probably by disturbing 
R helical structure. In addition, the study of C-terminal 
truncated Syncytin-1 variants indicates that 
cytoplasmic residues adjacent to the membrane 
domain, in particular residues 477-480, are required for 
optimal fusion induction probably by forming a helical 
structure, while residue 480 and those after 515 partly 
inhibit it. It is to be noted that the LQMV deletion, 
crucial for the fusogenic function of ERVWE1, is 
specific to ERVWE1 (as compared with paralogous 
HERV-W env copies). 
Proliferation: Recent data lead towards another as yet 
undescribed function of Syncytin-1. Indeed this 
envelope glycoprotein seems able to promote cell 
proliferation in the presence of TGF-beta3 and TGF-
beta1 in cultured cells. When Syncytin-1 production is 
blocked by an siRNA tool, TGF-beta does not lead to 
proliferation, indicating that Syncytin-1 is needed for 
the proliferation process. Conversely, in the absence of 
TGF-beta, Syncytin-1 leads to fusion. As TGF-beta 
does not changes the Syncytin-1 level, this suggests a 
control at the post-translational level. 
Anti-apoptotic potential: Syncytin-1 may exert an anti-
apoptotic function under certain conditions. It has 
indeed been demonstrated that stable transfection of 
Syncytin-1 into Syncytin-1-negative CHO cells 
efficiently prevents CHO cell apoptosis induced by 
staurosporine. This anti-apoptotic function might be
mediated by anti-apoptotic Bcl-2, as Bcl-2 upregulation 
was induced by Syncytin-1 expression in CHO cells, 
independently of staurosporine treatment. However, 
this anti-apoptotic potential remains to be confirmed in 
vivo. Interestingly, a significant reduction of Syncytin-
1 gene expression is observed in pathological placent  
along with a significant increase in apoptosis rate s 
compared with controls, both in vitro and in vivo. 
Cytotoxicity: Syncytin-1 expression can induce the 
activation of pro-inflammatory cytokines (IL-beta) 
(like other HERVs sequences) and redox-reactant 
release (iNOS), at least in astrocytes. In addition, 
ectopic expression of Syncytin-1 in an astrocytoma 
cell-line was shown to be associated with a lower 
activity of mitochondrial dehydrogenases. Although the
mechanisms mediating this effect remain unknown, this 
observation supports possible negative influences of 
ectopically expressed Syncytin-1 in multiple sclerosis. 
Immuno-suppression: Although the TM extracellular 
domain of Syncytin-1 contains a 25 AA so-called 
immunosuppressive peptide conserved and proposed to 
mediate immuno-suppression in many retroviral Env 
proteins, no direct evidence of an immunological 
function was demonstrated to date for the Syncytin-1. 
Nevertheless, Syncytin-1 is expressed at the cellular 
membrane of extravillous trophoblasts, which invade 
the spiral arteries of the maternal decidua. Because of 
this invasion by foetal cells, the maternal decidua 
should be a site of high immunological conflict, though 
the maternal immune system accepts the allogeneic 
embryo without general immunosuppression. This 
particular immune tolerance have been proposed to be 
mediated through DC-SIGN(+) dendritic cells, which 
proliferate in the decidua specifically at time of early 
pregnancy. Thus, the observed interaction between 
Syncytin-1 extracellular domain and DC-SIGN in vitro, 
may reflect an immunological property of the envelop  
glycoprotein. 
Retroviral infection:  
- Protection against retroviral infection  
Syncytin-1 confers host cell resistance to infection by 
the spleen necrosis virus, an exogenous retrovirus 
whose envelope protein also uses RDR to enter cells. 
This phenomenon is due to a competitive binding 
mechanism to receptor sites called 'receptor 
interference' and Syncytin-1 may confer host protection 
against infection by other exogenous retroviruses of the 
same interference group. 
- Ectopic retroviral infection  
Syncytin-1 can also pseudotype HIV-1 virions and 
confers on them a tropism for CD4 negative cells 
through interaction with the RDR receptors hASCT1 
and hASCT2, that are widely expressed in diverse 
human cell types. However, the unusually long 
intracytoplasmic tail of Syncytin-1 as compared with 
other type D or C retroviruses makes it suboptimal for 
formation of infectious viral pseudotypes. Indeed it 
might interfere with efficient processing of the 
precursor and/or incorporation of the processed env 
glycoprotein into virions. 
Mutations 
Note: The conservation of ERVWE1 provirus genomic 
localisation and envelope open reading frame have 
been screened in 155 individuals. They are conserved 
in all individuals tested so far. Moreover, sequencing of 
critical elements of ERVWE1, including the env ORF 
but also LTR elements involved in transcriptional 
regulation and the splice sites necessary to generate 
subgenomic env mRNA, showed striking conservation 
among the 24 individuals (48 alleles) analysed. All the 
polymorphic variants of Syncytin-1 are fusogenic. 
Envelope allelic variants: Five mutations have been 
found within Syncytin-1 ORF. One is a synonymous 
mutation, while the four others are non-synonymous. 
These non-synonymous mutations are dispersed among 
five Syncytin-1 protein variants: V129-R138-S307-
S477 (67% of the sequenced population), VRnS (25%), 
VqnS (4%), aRSS (2%), VqSf (2%). Each of the 24 
analyzed individuals had at least one of the two major 
genotypes, i.e. VRSS and VRnS. Altogether, amino-
acid variants (frequencies) are: AA129 V(0.979), 
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a(0.021); AA138 R(0.9375), q(0.0625); AA307 
S(0.7083), n(0.2917). All variants are functional and 
display the same fusogenicity. 
Germinal 
None yet described 
Somatic 
None yet described 
Implicated in 
Placental diseases 
Note: Placental Morphogenesis: In physiological 
conditions, Syncytin-1 is exclusively expressed in 
placenta cells, i.e. in cytotrophoblasts and more 
markedly in the syncytiotrophoblast layer, but not in 
placenta mesenchyme. Syncytin-1 is directly involved 
in the fusion of placenta villous cytotrophoblasts into 
the syncytiotrophoblast, which constitutes the interface 
layer between the mother and the developing foetus. 
Fusion occurs following Syncytin-1 interaction with 
hASCT2/hATB/SCL1A5 receptors, whose expression 
is restricted to cytotrophoblast cells. Neither local nor 
temporal variations of RDR/ASCT2 expression in 
villous cytotrophoblast cells seems to regulate the
fusion of placental trophoblast cells. Note that a 
modulation of cell surface expression of hASCT2 
appears associated with syncytialization of BeWo cells. 
The level of Syncytin-1 protein in villous trophoblasts 
increases during early pregnancy (at least from the 6  
to the 12th week of gestation) but is markedly reduced 
in late pregnancy. The syncytiotrophoblast is a 
polarized multinucleated layer, with its apical 
membrane facing the maternal blood circulation and  
the basal membrane facing the underlying 
cytotrophoblasts. Subcellular localization of syncytin-1 
within the syncytiotrophoblast has been investigated 
but observations are controversial. Thus Syncytin-1 
distribution has been described as diffuse within the
syncytial layer with enhancement at the apical 
membrane during all trimesters of pregnancy, while 
another analysis reports basal membrane localisation. 
In the latter report, the apical localisation occurred only 
in syncytiotrophoblasts from women with pre-
eclampsia (9 samples), and among them both basal and 
apical staining appeared once. 
Blocking Syncytin-1 proteins (at the translational or 
post-translational level) greatly reduced the fusion of 
cytotrophoblasts and syncytiotrophoblast formation but 
did not completely inhibit it indicating that there must 
be other proteins able to partially rescue the fusion of 
trophoblasts in the absence of Syncytin-1. One 
candidate is Syncytin-2, the envelope gene of an 
endogenous proviral copy from the HERV-FRD 
family. Indeed, even if this provirus is older than 
ERVWE1, the fusogenic property of Syncytin-2 has 
been also preserved and its expression is also high in 
the placenta. 
Syncytin-1 is also expressed, but at a much lower level, 
in all extravillous trophoblast types, at least in f rst 
trimester placentae. These cell types are CT cells of the 
implanting column, invading interstitial extravillous 
trophoblastic cells, multinucleated giant cells and 
endovascular trophoblasts. The role of Syncytin-1 in 
extravillous trophoblasts invading the maternal 
endometrium is not known. Extravillous trophoblasts 
are also giant polyploid cells, but this ploidy is thought 
to be the result of endoreplication rather than of cell-
cell fusion. 
Syncytin-1 may also play a role in villous or 
extravillous trophoblast proliferation in the presenc  of 
TGF-beta1 or TGFbeta3, in mediating immune-
tolerance through different mechanisms or in delayed 
syncytiotrophoblast apoptosis. 
Disease 
Pre-eclampsia: Pre-eclampsia (PE) and HELLP 
(haemolysis, elevated liver enzymes and low platelets) 
syndrome are multisystem disorders of pregnant 
women associated with placental abnormalities. Among 
these abnormalities are excessive proliferation of 
 
 
Figure 6: Syncytin-1 and hASCT2 localization in first trimester placental villi: Using specific antibodies, Syncytin-1 expression was mainly 
found located at the apical syncytiotrophoblast membrane, whereas hASCT2 receptor was expressed at the membrane of 
cytotrophoblastic cells underlying the syncytiotrophoblast. 
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cytotrophoblasts, defects in syncytiotrophoblast 
formation, increased number of syncytial knots of 
apoptotic nuclei and suboptimal invasion of 
trophoblasts. Syncytin-1 gene expression and protein 
levels are significantly reduced in PE and HELLP 
syndrome. Furthermore Syncytin-1 seems to be re-
distributed within the syncytiotrophoblast in pre-
eclamptic placenta. PE and HELLP syndrome are also 
characterised by hypoxia. Interestingly, hypoxia has 
been shown to inhibit cytotrophoblast fusion and to 
reduce the Syncytin-1 transcriptional level. Impaired 
cytotrophoblast cell-cell fusion observed in PE and 
HELLP syndrome is associated with increased 
apoptosis. This may correlate with Syncytin-1 down-
regulation, as Syncytin-1 have been suggested to have
anti-apoptotic potential in vitro. Thus, Syncytin-1 
down-regulation has been proposed to contribute to 
syncytiotrophoblast formation defects observed in these 
disorders and subsequent disturbed placental function. 
Placenta dysfunction associated with Down's 
syndrome/Trisomy 21: In trisomy 21-affected placenta, 
a defect (or a delay) in the syncytiotrophoblast 
formation and a decrease of the production of 
pregnancy-specific hormones have been observed. This 
has been related to the over-expression of SOD-1 (a 
key regulator of reactive oxygen species), located on 
chromosome 21. Surprisingly, in vitro, SOD-1 
overexpression has been shown to also reduce the 
Syncytin-1 expression level. 
Multiple sclerosis 
Note: MSRV, multiple sclerosis associated retrovirus, 
was found originally in retrovirus-like particles 
budding from leptomeningeal-cells from MS patients. 
MSRV is closely related to the HERV-W family and 
Syncytin-1. However, the sequencing of ERVWE1 
envelopes confirmed that the MSRV envelope 
(GenBank accession no. AF331500) was not encoded 
by the ERVWE1 locus. As ERVWE1 is the only W-
locus bearing a full-length envelope, it was proposed 
that MSRV particles may result either from 
transcomplementation of dispersed HERV-W copies 
simultaneously activated or from an as yet 
uncharacterised exogenous retrovirus. MSRV envelope 
has been proposed to exert various immune properties 
such as inducing immune response, triggering a 
superantigen effect, mediating cytokine production and 
activating innate immunity. 
Disease 
Multiple sclerosis (MS) is a complex inflammatory, 
auto-immune and demyelinating disease. Syncytin-1 is 
expressed in specific types of cells in the brain regions  
affected by MS. These cell types are the astrocytes, 
glial cells and activated macrophages of MS lesions. 
Syncytin-1 expression in astrocytes mediates 
neuroimmune activation and death of oligodendrocytes 
by inducing the release of redox reactants, cytotoxic for 
oligodendrocytes. In astrocytes, Syncytin-1 induces th  
expression of OASIS (old astocytes specifically 
induced substance), an endoplasmic reticulum stress 
sensor, which in turn leads to increased expression of 
inducible NO synthase and concurrent suppression of 
hASCT1 in astrocytes, resulting in diminished myelin 
protein production. 
What mechanisms reactivate Syncytin-1 in the brain in 
MS is still not clear. It could be the result of viral 
infection of the brain, such as herpes simplex virus, 
which has previously been shown to transactivate 
Syncytin-1 expression, or cytokine deregulation. 
Indeed it has been shown in astrocyte cultures that MS 
detrimental cytokines, IFN-gamma and TNF-alpha are 
able to induce Syncytin-1 expression through NF-
kappaB activation, while MS protective IFN-beta 
inhibits its expression. In addition Syncytin-1 induction 
by exogenous TNF-alpha into the corpus callosum, a 
region of the brain frequently exhibiting demyelinat on 
in MS, leads to neuroinflammation, diminished myelin 
proteins and neurobehavioural deficits in Syncytin-1-
transgenic mice, as observed in MS. Moreover in tur, 
endogenous TNF-alpha and other inflammatory 
cytokines are induced. These observed inductions 
seems to occur specifically in astrocytes. Another study 
from the same group reported an increase in ERVWE1 
DNA copy number, without evidence of new 
integration events or viral replication. Whether these 
sequences are episomal, result of endoreplication of 
part or the whole of chromosome 7 or belong to another 
retroviral sequence remains to be clarified. 
Expression of Syncytin-1, like of other members from 
the HERV-W and other HERV families, in the MS 
brain are not thought to be an aetiological factor but
more a consequence of increased immune activity, but 
it now seems clear that Syncytin-1 may have an 
important role in the pathogenesis of MS. 
Prognosis 
The presence of Syncytin-1 in MS may indicate a poor 
prognosis, as Syncytin-1 mediates the induction of 
redox reactants and causes oligodendrocyte death and 
demyelination. 
Other brain neuro-inflammatory 
diseases 
Note: HERV upregulation and their probable 
implication has been suggested in several other 
neurological disorders. However it has been shown that 
HERV-W env/ERVWE1 env mRNAs were not 
differentially regulated in schizophrenia and bipolar 
disorders compared with controls. 
Cancers 
Note: HERV expression/activation, including that of 
the HERV-W family seems to be a common feature in 
cancers, a phenomenon that has been linked to 
deregulation of methylation. However, whether they 
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are triggers or markers of carcinogenesis has still not 
been elucidated. HERV-W env sequences have been 
detected by EST or RT-PCR in several cancers such as 
brain cancer, kidney cancer, ovary cancer and skin 
cancer and in various cancer cell lines (Table 1). 
Conversely, ERVWE1/Syncytin-1 mRNA has been 
found in 38% of breast cancer specimens and in all 
benign and malignant endometria with the highest 
expression in endometrial carcinoma (EnCa). In these 
cases Syncytin-1 protein was concurrently expressed 
and there is evidence of fusion between cancerous cells 
expressing Syncytin-1 and endothelial cells. in vitro 
studies showed the involvement of Syncytin-1 in the
fusion process between breast cancer cell lines and 
endothelial cells, and in the fusion or the proliferation 
of EnCa. This last point is linked with cAMP-
stimulated cell-cell fusion or hormone-induced cell 
proliferation. Indeed steroid hormones induce both 
Syncytin-1 and TGF-beta1 and TGF-beta3, and the 
latters operate a switch in Syncytin-1 function from 
fusion to cell differentiation. 
Prognosis 
In breast cancers, the expression of Syncytin-1 may 
indicate a good prognosis, as suggested by one study. 
Indeed fusion between cancer and normal cells can 
either lead to restoration of the apoptosis cascade, or to 
cell differentiation, leading to a reduced tumorigenicity. 
However cancerous cells fusion may also lead on the 
contrary to a more aggressive phenotype, and, if fus on 
occurs with vascular endothelial cells, to metastasi . 
Furthermore, the cell proliferation and suggested anti-
apoptotic capacities of Syncytin-1 are more 
characteristics of oncogenes. 
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Table1: HERV-W, ERVWE1 and Syncytin-1 expression: Detection of HERV-W env mRNA transcripts by Northern blot (NB), RT-PCR, 
real-time RT-PCR (Q-RT-PCR), or by analysis of Expressed Sequence Tag (ESTs) databases. Depending on the method used (e.g. 
primers within the env ORF, primers overlapping splice junction,...), either only ERVWE1 specific transcripts are detected (labelled 
ERVWE1) or env-containing HERV-W transcripts are detected (labelled HERV-W). Relative expression of ERVWE1 transcripts in 
normal tissue is indicated in red (1,000-10,000), orange (10-100) and yellow (1-10). Whether ERVWE1 mRNA expression correlates 
with protein expression detected by immunocytochemistry (IM) or western blotting (WB) is indicated (glycoprotein detection is labelled 
Syncytin-1). Note that HERV-W mRNA expression does not preclude neither the presence nor the absence of ERVWE1 expression 
(labelled ERVWE1 and HERV-W when both are identified). 
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